
Aligning Artificial Intelligence and Laboratory Execution in Drug Discovery
From In Silico Design to In Vitro Impact

From In Silico Design to In Vitro Impact

Iktos, a French company specialized in artificial intelligence (AI) for new drug design, and Bayer’s Crop Science division announced a collaboration to expand the use of AI in the discovery and development of new sustainable crop protection products.

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.